No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs574033975 |
chr2:125239745-125239746 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs542667296 |
chr2:125239748-125239749 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs75916553 |
chr2:125239751-125239752 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs528784844 |
chr2:125239754-125239755 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs17011550 |
chr2:125239760-125239761 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs150743227 |
chr2:125239762-125239763 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs138000769 |
chr2:125239797-125239798 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs551105780 |
chr2:125239799-125239800 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs569659267 |
chr2:125239816-125239817 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs149398052 |
chr2:125239844-125239845 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs146371306 |
chr2:125239908-125239909 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs139740812 |
chr2:125239911-125239912 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs534950764 |
chr2:125239918-125239919 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs62172592 |
chr2:125239978-125239979 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs572991739 |
chr2:125240001-125240002 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs558076121 |
chr2:125240051-125240052 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs186416554 |
chr2:125240119-125240120 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs144516096 |
chr2:125240182-125240183 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs545168657 |
chr2:125240196-125240197 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs77580589 |
chr2:125240197-125240198 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs574068235 |
chr2:125240210-125240211 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs146045632 |
chr2:125240228-125240229 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs17011555 |
chr2:125240240-125240241 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
24 |
rs12464390 |
chr2:125240243-125240244 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs191763876 |
chr2:125240251-125240252 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs565239511 |
chr2:125240260-125240261 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs183619449 |
chr2:125240283-125240284 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs531068055 |
chr2:125240303-125240304 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs530375329 |
chr2:125240326-125240327 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs544494441 |
chr2:125240382-125240383 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs561505004 |
chr2:125240385-125240386 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs529007269 |
chr2:125240406-125240407 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs549047149 |
chr2:125240407-125240408 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs565720551 |
chr2:125240423-125240424 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs563346450 |
chr2:125240448-125240449 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs142293305 |
chr2:125240472-125240473 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs151269535 |
chr2:125240547-125240548 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs537320486 |
chr2:125240548-125240549 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs556902396 |
chr2:125240572-125240573 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs567436266 |
chr2:125240581-125240582 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs187793966 |
chr2:125240612-125240613 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs192305511 |
chr2:125240630-125240631 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs529203054 |
chr2:125240649-125240650 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs73952986 |
chr2:125240679-125240680 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs548466124 |
chr2:125240766-125240767 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs558487406 |
chr2:125240772-125240773 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs529211258 |
chr2:125240807-125240808 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs575554102 |
chr2:125240819-125240820 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs550874647 |
chr2:125240847-125240848 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs182270140 |
chr2:125240851-125240852 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|